Meng Xiangnv, Lu Zhongting, Mi Fu, Sha Sha, Li Tao
General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Second Department of Medical Oncology, Cangzhou Central Hospital, Cangzhou, Hebei, China.
Discov Oncol. 2025 May 16;16(1):789. doi: 10.1007/s12672-025-02632-x.
Targeted therapy has significantly transformed the treatment landscape of colorectal cancer (CRC), enabling personalized treatment approaches and improving patient prognosis. This study employs bibliometric analysis to explore the research hotspots and development trends in the field of CRC-targeted therapy from 2000 to 2023.
Based on the Web of Science Core Collection, this study collected literature related to CRC-targeted therapy published between 2000 and 2023. CiteSpace and VOSviewer were used for data analysis, with a focus on publication trends, key contributors, and keyword co-occurrence patterns.
A total of 2252 relevant articles were included, demonstrating a steady growth trend in research output. China ranked first in terms of the number of publications, while the University of Texas MD Anderson Cancer Center was identified as the institution with the highest research output. Josep Tabernero was the most prolific author in this field. Among journals, Cancers had the highest impact, while Clinical Cancer Research held a significant advantage in citation frequency. Keyword co-occurrence and clustering analysis indicated that research primarily focused on treatment strategies and precision medicine, with emerging technologies such as cell therapy and liquid biopsy garnering increasing attention.
This study reveals the research trends, core hotspots, and emerging directions in the field of CRC-targeted therapy, providing valuable insights for future research.
靶向治疗显著改变了结直肠癌(CRC)的治疗格局,实现了个性化治疗方法并改善了患者预后。本研究采用文献计量分析方法,以探索2000年至2023年期间CRC靶向治疗领域的研究热点和发展趋势。
基于科学网核心合集,本研究收集了2000年至2023年间发表的与CRC靶向治疗相关的文献。使用CiteSpace和VOSviewer进行数据分析,重点关注发表趋势、主要贡献者和关键词共现模式。
共纳入2252篇相关文章,研究产出呈稳步增长趋势。中国在发表数量方面排名第一,而德克萨斯大学MD安德森癌症中心被确定为研究产出最高的机构。何塞普·塔贝尼罗是该领域发文最多的作者。在期刊方面,《Cancers》影响力最高,而《临床癌症研究》在被引频次方面具有显著优势。关键词共现和聚类分析表明,研究主要集中在治疗策略和精准医学,细胞治疗和液体活检等新兴技术受到越来越多的关注。
本研究揭示了CRC靶向治疗领域的研究趋势、核心热点和新兴方向,为未来研究提供了有价值的见解。